Idarubicin Injection 20 mg/20 mL (3)

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

idarubicin hydrochloride, Quantity: 1 mg/mL

제공처:

Pfizer (Perth) Pty Ltd

약제 형태:

Injection, solution

구성:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

관리 경로:

Intravenous

패키지 단위:

1 x 20 mL

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

UK: Zavedos is used in adults and children for the treatment of acute non lymphoblastic leukaemia (ANLL), also referred to as acute myeloid leukaemia (AML). Zavedos is also used in adults and children as a second line treatment of relapsed acute lymphoblastic leukaemia (ALL)

제품 요약:

Visual Identification: Red - orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Listed (Export Only)

승인 날짜:

2023-02-17